|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.000197124
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.000177838
|
|
|
lymphokine deficiency
|
[NCBI]
|
0.000151467
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
0.00011323
|
|
|
LIS2
|
[NCBI]
|
9.73573e-05
|
|
|
DYX2
|
[NCBI]
|
7.54356e-05
|
|
|
PTK2
|
[NCBI]
|
7.53053e-05
|
|
|
HIGM1
|
[NCBI]
|
6.08411e-05
|
|
|
IL8
|
[NCBI]
|
5.44234e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
4.29609e-05
|
|
|
ZS
|
[NCBI]
|
4.25236e-05
|
|
|
CEACAM5
|
[NCBI]
|
3.49126e-05
|
|
|
RGS1
|
[NCBI]
|
3.48838e-05
|
|
|
DCDC2
|
[NCBI]
|
3.48838e-05
|
|
|
JAM1
|
[NCBI]
|
3.1841e-05
|
|
|
CCL18
|
[NCBI]
|
2.79252e-05
|
|
|
MPO
|
[NCBI]
|
2.71175e-05
|
|
|
LGALS3
|
[NCBI]
|
2.6169e-05
|
|
|
SLE
|
[NCBI]
|
2.42842e-05
|
|
|
FPRL1
|
[NCBI]
|
2.41344e-05
|
|
|
VIP
|
[NCBI]
|
2.3945e-05
|
|
|
TIMP3
|
[NCBI]
|
2.39233e-05
|
|
|
MG
|
[NCBI]
|
2.29109e-05
|
|
|
CFI
|
[NCBI]
|
2.27947e-05
|
|
|
TNF
|
[NCBI]
|
2.12702e-05
|
|
|
RELN
|
[NCBI]
|
2.09101e-05
|
|
|
CD47
|
[NCBI]
|
2.06674e-05
|
|
|
MMP9
|
[NCBI]
|
1.93925e-05
|
|
|
CCL17
|
[NCBI]
|
1.87608e-05
|
|
|
CCL22
|
[NCBI]
|
1.78169e-05
|
|
|
SRC
|
[NCBI]
|
1.59736e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.58627e-05
|
|
|
FMF
|
[NCBI]
|
1.33252e-05
|
|
|
ILK
|
[NCBI]
|
1.19382e-05
|
|
|
GHRH
|
[NCBI]
|
8.77928e-06
|
|
|
MBP
|
[NCBI]
|
7.37596e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.7866e-06
|
|
|
ADCYAP1
|
[NCBI]
|
6.04754e-06
|
|
|
PPARA
|
[NCBI]
|
4.29819e-06
|
|
|
TG
|
[NCBI]
|
3.82762e-06
|
|
|
TNFSF6
|
[NCBI]
|
2.7124e-06
|
|
|
CAT
|
[NCBI]
|
1.48876e-06
|
|
|
HGF
|
[NCBI]
|
9.24308e-07
|
|
|
VEGF
|
[NCBI]
|
8.8993e-07
|
|
|
APOE
|
[NCBI]
|
8.58403e-07
|
|
|
GFAP
|
[NCBI]
|
2.46787e-07
|
|
|
EGF
|
[NCBI]
|
2.10109e-07
|
|
|
PCNA
|
[NCBI]
|
8.13531e-08
|
|
|
PRL
|
[NCBI]
|
6.58156e-08
|
|
|
PTH
|
[NCBI]
|
2.03031e-08
|
|
|
CF
|
[NCBI]
|
2.85356e-09
|
|